Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Evelyn Sbar

Pain Medicine Amarillo, TX Medical Doctor

NPI 1871579086 CMS profile 1185170

1400 S Coulter St, Amarillo, TX 79106

Open in the dashboard

General payments

$51,732

155 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Evelyn Sbar of Amarillo, TX is reported in the CMS Open Payments database as having received $51,732 across 155 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $17,568 54
2021 General $33,780 88
2020 General $98 6
2019 General $286 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Evelyn Sbar
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Evelyn Sbar were reported at $0. Among 757 Pain Medicine profiles paid that year, the median was $470 and the middle half received between $146 and $1,462.

Show as a table
Year Evelyn Sbar Pain Medicine median Middle half National median
2019 $286 $506 $144–$1,566 $163
2020 $98 $315 $96–$934 $114
2021 $33,780 $452 $134–$1,237 $132
2022 $17,568 $475 $124–$1,407 $149
2023 $0 $480 $136–$1,384 $160
2024 $0 $521 $164–$1,511 $164
2025 $0 $470 $146–$1,462 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. AbbVie, Inc. $28,928 51 payments
  2. Biohaven Pharmaceuticals, Inc. $8,180 32 payments
  3. Teva Pharmaceuticals USA, Inc. $6,087 33 payments
  4. Biohaven Pharmaceutical Holding Company Ltd. $5,426 17 payments
  5. Allergan Inc. $1,750 1 payment
  6. Amgen Inc. $788 1 payment
  7. Astellas Pharma US Inc $139 4 payments
  8. Lundbeck LLC $98 1 payment
  9. Upsher-Smith Laboratories LLC $90 4 payments
  10. LivaNova USA, Inc. $88 1 payment
  11. Other $158 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $49,103 26 payments
  2. Food and Beverage $2,447 126 payments
  3. Travel and Lodging $93 2 payments
  4. Education $90 1 payment
Products named General payments · program years 2019–2022
  1. UBRELVY $28,109 41 payments
  2. NURTEC ODT $13,607 49 payments
  3. AJOVY Central Nervous System $5,967 30 payments
  4. QULIPTA $2,569 11 payments
  5. AIMOVIG $788 1 payment
  6. Ajovy Central Nervous System $112 1 payment
  7. VYEPTI $98 1 payment
  8. TOSYMRA $90 4 payments
  9. ZEMBRACE SYMTOUCH $90 4 payments
  10. VNS Therapy $88 1 payment
  11. Other $295 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

155 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record